Pharmacy Times

JULY 19, 2025

Signal Transduction Targeted Therapy 2020; 5:101. Jansen, PharmD Candidate , Mark A. Malesker, PharmD, FCCP, FCCM, FASHP, BCPS +1 More Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action. Presented at ACC/WCC 2023. March 4, 2023. New Orleans.

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 25, 2025

Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Arthritis Care Res ( Hoboken ). 2021;73(1):1-9.

HIV Treatment and Prevention Agents

Pharmacy Times

AUGUST 2, 2025

Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus. doi:10.1136/bmjdrc-2020-001248 5. Nieto, BS, PharmD Candidate Amy C. Nieto explains essential guidelines for managing diabetes during Ramadan, ensuring safe fasting practices and optimal health for patients.

Diabetes

Pharmacy Times

JULY 31, 2025

Published Online May 19, 2020. Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Ganaie F, Saad JS, McGee L, et al. Accessed July 31, 2025. doi:11:10.1128/mbio.00937-20.

Pharmacy Technician

Pharmacy Times

AUGUST 5, 2025

but below 2020 high. link] Flu vaccination coverage, United States, 2023-24 influenza season. September 20, 2024. Accessed June 10, 2025. link] FluVaxView. Accessed June 10, 2025. link] Brenan M. Nurses retain top ethics rating in U.S., January 10, 2023. Accessed June 10, 2025.

Pharmacy Technician

Pharmacy Times

JUNE 9, 2025

trillion economic impact in 2020. trillion economic impact in 2020. trillion (about $4600 per capita in the US) in 2020. LIMITX technology, developed by Abuse Deterrent Pharma and Acura Pharmaceuticals, controls drug release to reduce overdose risk.

Pharmacy Technician

Pharmacy Times

JULY 22, 2025

While the European Medicines Agency mandated pre-treatment DPD testing in Europe as early as 2020, and the UK’s National Health Service followed suit the same year, the US only reached a consensus in 2025.

Pharmacy Technician

Pharmacy Times

JUNE 16, 2025

The first one was introduced on September 13, 2020, near the end of Trump’s first term, but was shut down by a federal judge due to the administration’s failure to comply with the proper implementation processes.

Pharmacy Technician

Pharmacy Times

JULY 24, 2025

Patients with ankylosing spondylitis may be able to receive the same benefits as reference adalimumab (Humira; AbbVie) at a lower cost by using IBI303 (Innovent Biologics), a biosimilar, wrote authors of research published in Medicine (Baltimore).

Biosimilars

Pharmacy Times

JULY 2, 2025

On February 21, 2020, the FDA approved eptinezumab-jjmr (Vyepti; Lundbeck) as the first intravenous migraine preventative treatment for adults. Pharmacists are essential in managing access, patient education, and monitoring outcomes, ensuring adherence and addressing administrative challenges.

Pharmacy Technician

Pharmacy Times

JULY 28, 2025

VMAT2 Inhibitors Updated in 2020, American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia (Third Edition) and A Modified Delphi Consensus Study of the Screening, Diagnosis, and Treatment of Tardive Dyskinesia recommend treatment with a VMAT2 inhibitor for patients with TD.

Pharmacy Technician

Pharmacy Times

JUNE 25, 2025

Updated January 22, 2020. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. months versus 7.79 months with tislelizumab. months versus 7.79 months with tislelizumab. Accessed June 25, 2025.

Chemotherapy

Pharmacy Times

JULY 15, 2025

Since launching Amazon Pharmacy in November of 2020, we've made it easier for patients to access low-priced medications and have them delivered to their door. Common barriers that I think of include access and cost, but also treatment complexity and forgetfulness.

Pharmacy Technician

Pharmacy Times

JULY 8, 2025

Anti-TNFs remain the only FDA-approved class for pediatric IBD, prompting biosimilar use for cost and accessibility. The study found no significant differences in biosimilar use by age, race, or ethnicity, but regional variations existed. SHOW MORE The study found biosimilar initiation rose to nearly 42% from 2016 to 2023.

Biosimilars

Pharmacy Times

AUGUST 5, 2025

Contrastingly, during the pandemic years of 2020 and 2021, the hospitalization rate was significantly lower, at 2.3% The authors defined complicated pneumonia as a severe illness involving at least 1 local complication. 1 Between January 2019 and December 2024, 305 pediatric patients with CAP were admitted to TUH. and 5.6%, respectively.

Pharmacy Technician

Pharmacy Times

JULY 18, 2025

Updated May 6, 2020. link] Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry, January 2018. Accessed June 9, 2025. link] FDA Drug Shortages. Updated December 19, 2024. Accessed June 9, 2025.

Compounding

Pharmacy Times

JULY 1, 2025

Using data from the National Cancer Database, they performed a retrospective analysis on patients diagnosed with metastatic HR–/HER2+ breast cancer between January 2013 and December 2020. The patients were assigned to 1 of 2 groups: those who received HER2-targeting therapies and those who did not. 3 Among the patients, approximately 75.8%

Pharmacy Technician

Pharmacy Times

AUGUST 6, 2025

Cardiovascular Health, 2010 to 2020: A Systematic Review of a Decade of Research on Life's Simple 7. Our goal is to improve measures of cardiovascular health and prevent chronic diseases from head to toe.” 2 REFERENCES 1. Aguayo L, Cotoc C. Journal of the American Heart Association. doi.org/10.1161/JAHA.124.038566 124.038566 2.

Pharmacy Technician

Pharmacy Times

JUNE 30, 2025

Supreme Court’s decision not to review a pharmacy benefit manager reform case out of Oklahoma: “After the historic Rutledge v. Douglas Hoey on the U.S.

Pharmacy Technician

Pharmacy Times

JUNE 18, 2025

PTCy recipients included those who received peripheral blood stem cells of haploidentical-related and mismatched unrelated donor transplants.

Pharmacy Technician

Pharmacy Times

JUNE 11, 2025

13510 Nutrition Counseling Coverage Act of 2021, HR 6971, 116th Cong (2019-2020). link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Clinical interventions for food-drug interactions: a pharmacist’s perspective.

Pharmacy Technician

Pharmacy Times

JUNE 27, 2025

August 5, 2020. Study of single agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone (Pom/​Dex) in participants with relapsed/​refractory multiple myeloma (RRMM) (DREAMM-3). Updated June 10, 2025. Accessed June 27, 2025. FDA granted accelerated approval to belantamab mafodotin-blmf for multiple myeloma.

Pharmacy Technician